Jeffrey Schwartz

Title: Jeffrey Schwartz: Innovator in Cancer Treatment

Introduction

Jeffrey Schwartz is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His focus on compositions for the treatment of metastatic cancer showcases his dedication to improving patient outcomes.

Latest Patents

Jeffrey Schwartz holds a patent for "Compositions for the treatment of metastatic cancer." This patent discloses compositions aimed at the treatment, prevention of, proliferation of, or killing of cells associated with metastatic progression of cancer in a cancer patient. The compositions include a single type of glyceride, fatty acid, or fatty acid derivative, as well as mixtures thereof. Additionally, these compositions can be combined with cancer metabolism disruptors, chemotherapeutics, and modulators of immune response. The formulations disclosed include monolaurin and methods for treating metastatic cancer and preventing cancer relapse.

Career Highlights

Throughout his career, Jeffrey Schwartz has focused on developing innovative solutions for complex medical challenges. His work has led to advancements in the treatment of cancer, particularly in targeting circulating cancer cells that contribute to metastasis and relapse. His dedication to research and development has positioned him as a key figure in the field of oncology.

Collaborations

Jeffrey Schwartz collaborates with Robert G Shorr, enhancing the research and development efforts at Biodev, LLC. Their partnership aims to further explore and refine cancer treatment methodologies.

Conclusion

Jeffrey Schwartz's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the lives of cancer patients, offering hope for more effective treatments.